Feilong Zhou

845 total citations
45 papers, 635 citations indexed

About

Feilong Zhou is a scholar working on Molecular Biology, Pharmaceutical Science and Renewable Energy, Sustainability and the Environment. According to data from OpenAlex, Feilong Zhou has authored 45 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Pharmaceutical Science and 10 papers in Renewable Energy, Sustainability and the Environment. Recurrent topics in Feilong Zhou's work include Electrocatalysts for Energy Conversion (10 papers), Advanced Drug Delivery Systems (8 papers) and Advancements in Transdermal Drug Delivery (6 papers). Feilong Zhou is often cited by papers focused on Electrocatalysts for Energy Conversion (10 papers), Advanced Drug Delivery Systems (8 papers) and Advancements in Transdermal Drug Delivery (6 papers). Feilong Zhou collaborates with scholars based in China, Australia and United States. Feilong Zhou's co-authors include Runliang Feng, Zhimei Song, Jie Zhang, Ruilin Wang, Jinwei Chen, Yujun Zhao, Hongmei Xu, Ziqin Yan, Gang Wang and Ning Meng and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Colloid and Interface Science and Journal of Medicinal Chemistry.

In The Last Decade

Feilong Zhou

44 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feilong Zhou China 17 172 116 114 113 93 45 635
Narges Ajalli Iran 18 174 1.0× 47 0.4× 263 2.3× 44 0.4× 72 0.8× 27 694
Kalpesh Vaghasiya India 18 150 0.9× 39 0.3× 145 1.3× 17 0.2× 119 1.3× 26 643
V. Chandrakala India 5 98 0.6× 44 0.4× 179 1.6× 43 0.4× 54 0.6× 11 592
Mahwash Mukhtar Hungary 19 247 1.4× 24 0.2× 230 2.0× 46 0.4× 159 1.7× 26 819
Chao‐Hsuan Chen Taiwan 13 230 1.3× 14 0.1× 70 0.6× 65 0.6× 69 0.7× 41 629
Shengmei Wang China 16 205 1.2× 31 0.3× 65 0.6× 66 0.6× 33 0.4× 38 618
Changhao Wang China 18 557 3.2× 26 0.2× 153 1.3× 60 0.5× 34 0.4× 47 982
Huizhu Zhang China 15 192 1.1× 27 0.2× 199 1.7× 17 0.2× 100 1.1× 37 722

Countries citing papers authored by Feilong Zhou

Since Specialization
Citations

This map shows the geographic impact of Feilong Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feilong Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feilong Zhou more than expected).

Fields of papers citing papers by Feilong Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feilong Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feilong Zhou. The network helps show where Feilong Zhou may publish in the future.

Co-authorship network of co-authors of Feilong Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Feilong Zhou. A scholar is included among the top collaborators of Feilong Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feilong Zhou. Feilong Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qin, Min, et al.. (2025). Identification of high corrosion failure probability in shale gas gathering and transportation pipeline segments. Engineering Failure Analysis. 177. 109717–109717. 1 indexed citations
2.
Li, Na, Yongyan Zhang, Jinming Liu, et al.. (2024). Reduction of circulating IgE and allergens by a pH-sensitive antibody with enhanced FcγRIIb binding. Molecular Therapy. 32(10). 3729–3742. 1 indexed citations
3.
Lou, Yan, et al.. (2024). Identification of novel indolinone derivatives as CTSC inhibitors to treat inflammatory bowel disease by modulating inflammatory factors. European Journal of Medicinal Chemistry. 280. 116914–116914. 3 indexed citations
4.
Chen, Jingru, Feilong Zhou, Yuan Wang, et al.. (2024). Reprogramming macrophage by targeting VEGF and CD40 potentiates OX40 immunotherapy. Biochemical and Biophysical Research Communications. 698. 149546–149546. 1 indexed citations
5.
Zhou, Feilong, Yizhu Wang, Yanlong Shi, et al.. (2024). Emerging discoveries on the role of TRIM14: from diseases to immune regulation. Cell Death Discovery. 10(1). 513–513. 1 indexed citations
6.
Chen, Jinhua, Chunlei Wang, Feilong Zhou, et al.. (2024). An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine pancreatic cancer. Biochemical and Biophysical Research Communications. 718. 149931–149931. 5 indexed citations
7.
Liu, Chen, Ziqin Yan, Xiancheng Wang, et al.. (2024). Synthesis and biological evaluation of 4-imidazolidinone–containing compounds as potent inhibitors of the MDM2/p53 interaction. European Journal of Medicinal Chemistry. 270. 116366–116366. 3 indexed citations
8.
Zhou, Feilong, et al.. (2023). Artificial intelligence in small molecule drug discovery from 2018 to 2023: Does it really work?. Bioorganic Chemistry. 141. 106894–106894. 22 indexed citations
9.
Lu, Yuhang, Jing Cheng, Feilong Zhou, et al.. (2022). A chemical perspective on the modulation of TEAD transcriptional activities: Recent progress, challenges, and opportunities. European Journal of Medicinal Chemistry. 243. 114684–114684. 23 indexed citations
10.
Yan, Ziqin, Feilong Zhou, Xilin Lyu, et al.. (2022). Discovery of a selective and covalent small-molecule inhibitor of BFL-1 protein that induces robust apoptosis in cancer cells. European Journal of Medicinal Chemistry. 236. 114327–114327. 7 indexed citations
11.
Chen, Deheng, Tian Lu, Ziqin Yan, et al.. (2019). Discovery, structural insight, and bioactivities of BY27 as a selective inhibitor of the second bromodomains of BET proteins. European Journal of Medicinal Chemistry. 182. 111633–111633. 45 indexed citations
12.
Zhou, Feilong, et al.. (2019). Transdermal delivery of curcumin-loaded supramolecular hydrogels for dermatitis treatment. Journal of Materials Science Materials in Medicine. 30(1). 11–11. 29 indexed citations
13.
Song, Zhimei, Feilong Zhou, Hongmei Xu, et al.. (2018). Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B. Carbohydrate Polymers. 205. 571–580. 26 indexed citations
14.
Li, Shida, Hongmei Xu, Feilong Zhou, et al.. (2018). MPEG-PCL Copolymeric Micelles for Encapsulation of Azithromycin. AAPS PharmSciTech. 19(5). 2041–2047. 21 indexed citations
15.
16.
Song, Zhimei, et al.. (2017). Enhanced effect in combination of curcumin- and ketoconazole-loaded methoxy poly (ethylene glycol)-poly (ε-caprolactone) micelles. Biomedicine & Pharmacotherapy. 88. 43–51. 20 indexed citations
17.
Wang, Yichun, Jinwei Chen, Feilong Zhou, et al.. (2017). Graphene oxide-assisted facile synthesis of platinum–tellurium nanocubes with enhanced catalytic activity for formic acid electro-oxidation. Nanotechnology. 28(33). 335701–335701. 6 indexed citations
18.
Zhang, Jie, Jinwei Chen, Haowei Yang, et al.. (2017). Efficient synthesis of nitrogen-doped carbon with flower-like tungsten nitride nanosheets for improving the oxygen reduction reactions. RSC Advances. 7(54). 33921–33928. 14 indexed citations
19.
Song, Zhimei, et al.. (2016). Development on PEG-modified Poly (Amino Acid) Copolymeric Micelles for Delivery of Anticancer Drug. Anti-Cancer Agents in Medicinal Chemistry. 17(6). 784–801. 4 indexed citations
20.
Feng, Runliang, et al.. (2016). Glycyrrhetinic acid-modified PEG-PCL copolymeric micelles for the delivery of curcumin. Reactive and Functional Polymers. 111. 30–37. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Narges Ajalli Breakdown of academic impact, for papers by Kalpesh Vaghasiya Breakdown of academic impact, for papers by V. Chandrakala Breakdown of academic impact, for papers by Mahwash Mukhtar Breakdown of academic impact, for papers by Chao‐Hsuan Chen Breakdown of academic impact, for papers by Shengmei Wang Breakdown of academic impact, for papers by Changhao Wang Breakdown of academic impact, for papers by Huizhu Zhang
Rankless by CCL
2026